Oelisoa Mireille Andriankaja
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Periodontal Diseases | 4 | 2012 | 49 | 0.930 |
Why?
|
| Myocardial Infarction | 3 | 2011 | 242 | 0.720 |
Why?
|
| Tooth | 1 | 2018 | 11 | 0.580 |
Why?
|
| Gingivitis | 1 | 2018 | 9 | 0.570 |
Why?
|
| Insulin Resistance | 1 | 2018 | 199 | 0.490 |
Why?
|
| Periodontitis | 5 | 2017 | 56 | 0.480 |
Why?
|
| Periodontal Pocket | 2 | 2011 | 6 | 0.440 |
Why?
|
| Overweight | 2 | 2016 | 248 | 0.430 |
Why?
|
| Obesity | 3 | 2019 | 1131 | 0.370 |
Why?
|
| Inflammation | 4 | 2018 | 729 | 0.330 |
Why?
|
| Middle Aged | 12 | 2019 | 11819 | 0.260 |
Why?
|
| Periodontal Index | 3 | 2017 | 10 | 0.250 |
Why?
|
| Longitudinal Studies | 3 | 2019 | 1020 | 0.240 |
Why?
|
| Coronary Disease | 1 | 2006 | 123 | 0.230 |
Why?
|
| Aged | 7 | 2018 | 7982 | 0.230 |
Why?
|
| Alveolar Bone Loss | 3 | 2013 | 19 | 0.220 |
Why?
|
| Smoking | 2 | 2010 | 1019 | 0.220 |
Why?
|
| Lipid Peroxidation | 2 | 2016 | 141 | 0.210 |
Why?
|
| Adult | 10 | 2019 | 13458 | 0.210 |
Why?
|
| Periodontal Attachment Loss | 3 | 2016 | 9 | 0.190 |
Why?
|
| Adiposity | 2 | 2019 | 155 | 0.160 |
Why?
|
| Risk Factors | 4 | 2019 | 3942 | 0.150 |
Why?
|
| Hypertension | 2 | 2019 | 823 | 0.150 |
Why?
|
| Humans | 14 | 2019 | 42163 | 0.140 |
Why?
|
| Glucose Intolerance | 1 | 2017 | 41 | 0.130 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2016 | 744 | 0.120 |
Why?
|
| Case-Control Studies | 2 | 2011 | 1266 | 0.120 |
Why?
|
| Dyslipidemias | 1 | 2016 | 48 | 0.120 |
Why?
|
| Glucose Tolerance Test | 2 | 2017 | 76 | 0.120 |
Why?
|
| Blood Pressure | 1 | 2019 | 662 | 0.120 |
Why?
|
| Actinobacillus Infections | 2 | 2012 | 4 | 0.120 |
Why?
|
| Sex Factors | 2 | 2010 | 1008 | 0.120 |
Why?
|
| Cross-Sectional Studies | 4 | 2017 | 3077 | 0.120 |
Why?
|
| Male | 9 | 2019 | 22779 | 0.110 |
Why?
|
| C-Reactive Protein | 1 | 2015 | 164 | 0.110 |
Why?
|
| Female | 9 | 2019 | 24018 | 0.110 |
Why?
|
| Porphyromonas gingivalis | 2 | 2011 | 39 | 0.110 |
Why?
|
| Pasteurellaceae Infections | 1 | 2013 | 2 | 0.110 |
Why?
|
| Lipids | 1 | 2015 | 256 | 0.110 |
Why?
|
| Diabetes Complications | 1 | 2013 | 99 | 0.100 |
Why?
|
| Aggressive Periodontitis | 1 | 2012 | 2 | 0.090 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2013 | 126 | 0.090 |
Why?
|
| Asthma | 1 | 2016 | 410 | 0.090 |
Why?
|
| Prevotella intermedia | 1 | 2011 | 1 | 0.090 |
Why?
|
| Campylobacter rectus | 1 | 2011 | 1 | 0.090 |
Why?
|
| Bacteroidaceae Infections | 1 | 2011 | 7 | 0.090 |
Why?
|
| Campylobacter Infections | 1 | 2011 | 8 | 0.090 |
Why?
|
| Tumor Necrosis Factor-alpha | 4 | 2016 | 379 | 0.090 |
Why?
|
| Caspase 3 | 1 | 2012 | 226 | 0.090 |
Why?
|
| Models, Animal | 1 | 2011 | 149 | 0.090 |
Why?
|
| Fusobacterium Infections | 1 | 2011 | 7 | 0.090 |
Why?
|
| Fusobacterium nucleatum | 1 | 2011 | 9 | 0.090 |
Why?
|
| Confidence Intervals | 1 | 2011 | 162 | 0.090 |
Why?
|
| Hypertriglyceridemia | 1 | 2010 | 16 | 0.080 |
Why?
|
| Obesity, Abdominal | 1 | 2010 | 29 | 0.080 |
Why?
|
| Microscopy, Fluorescence | 1 | 2011 | 254 | 0.080 |
Why?
|
| Cholesterol, HDL | 1 | 2010 | 99 | 0.080 |
Why?
|
| Host-Pathogen Interactions | 1 | 2011 | 203 | 0.080 |
Why?
|
| Homeostasis | 1 | 2011 | 193 | 0.080 |
Why?
|
| Hyperglycemia | 1 | 2010 | 60 | 0.080 |
Why?
|
| Odds Ratio | 1 | 2011 | 587 | 0.080 |
Why?
|
| Multivariate Analysis | 1 | 2011 | 638 | 0.080 |
Why?
|
| Blood Glucose | 1 | 2011 | 386 | 0.080 |
Why?
|
| Educational Status | 1 | 2010 | 335 | 0.070 |
Why?
|
| Mexican Americans | 1 | 2010 | 224 | 0.070 |
Why?
|
| Antihypertensive Agents | 1 | 2010 | 285 | 0.070 |
Why?
|
| Apoptosis | 2 | 2013 | 1541 | 0.070 |
Why?
|
| New York | 1 | 2007 | 88 | 0.070 |
Why?
|
| Age Factors | 1 | 2010 | 1139 | 0.070 |
Why?
|
| Alveolar Process | 1 | 2006 | 3 | 0.060 |
Why?
|
| Diabetes Mellitus | 1 | 2012 | 532 | 0.060 |
Why?
|
| Epidemiologic Methods | 1 | 2006 | 56 | 0.060 |
Why?
|
| Tooth Loss | 1 | 2006 | 39 | 0.060 |
Why?
|
| Waist Circumference | 2 | 2019 | 90 | 0.060 |
Why?
|
| Rats | 4 | 2013 | 3701 | 0.050 |
Why?
|
| Aged, 80 and over | 1 | 2010 | 2803 | 0.050 |
Why?
|
| Osteoclasts | 2 | 2013 | 28 | 0.050 |
Why?
|
| Body Mass Index | 2 | 2019 | 916 | 0.050 |
Why?
|
| Antibodies, Bacterial | 2 | 2012 | 117 | 0.040 |
Why?
|
| Rats, Wistar | 2 | 2012 | 282 | 0.040 |
Why?
|
| Systole | 1 | 2019 | 67 | 0.040 |
Why?
|
| Diastole | 1 | 2019 | 47 | 0.040 |
Why?
|
| Blood Pressure Determination | 1 | 2019 | 53 | 0.040 |
Why?
|
| Young Adult | 1 | 2010 | 4936 | 0.040 |
Why?
|
| United States | 1 | 2010 | 5072 | 0.040 |
Why?
|
| Anti-Bacterial Agents | 2 | 2012 | 415 | 0.040 |
Why?
|
| Dental Plaque Index | 1 | 2016 | 5 | 0.030 |
Why?
|
| Animals | 4 | 2013 | 16695 | 0.030 |
Why?
|
| Puerto Rico | 1 | 2019 | 1376 | 0.030 |
Why?
|
| Antioxidants | 1 | 2016 | 439 | 0.020 |
Why?
|
| Cardiovascular Diseases | 1 | 2019 | 729 | 0.020 |
Why?
|
| Gingival Crevicular Fluid | 1 | 2012 | 2 | 0.020 |
Why?
|
| Cytokines | 1 | 2016 | 661 | 0.020 |
Why?
|
| Malondialdehyde | 1 | 2012 | 42 | 0.020 |
Why?
|
| Kanamycin | 1 | 2012 | 5 | 0.020 |
Why?
|
| Ampicillin | 1 | 2012 | 7 | 0.020 |
Why?
|
| Epithelial Attachment | 1 | 2012 | 3 | 0.020 |
Why?
|
| Neutrophil Activation | 1 | 2012 | 9 | 0.020 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2012 | 24 | 0.020 |
Why?
|
| Bacterial Adhesion | 1 | 2012 | 40 | 0.020 |
Why?
|
| Ligation | 1 | 2011 | 12 | 0.020 |
Why?
|
| Treponema denticola | 1 | 2011 | 5 | 0.020 |
Why?
|
| Bacteroides | 1 | 2011 | 10 | 0.020 |
Why?
|
| Rats, Inbred Strains | 1 | 2011 | 132 | 0.020 |
Why?
|
| Mandible | 1 | 2011 | 12 | 0.020 |
Why?
|
| Injections | 1 | 2011 | 40 | 0.020 |
Why?
|
| Skull | 1 | 2011 | 27 | 0.020 |
Why?
|
| Immunization | 1 | 2011 | 93 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2012 | 165 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2012 | 167 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2011 | 256 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2012 | 487 | 0.020 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2012 | 181 | 0.020 |
Why?
|
| Immunoglobulin G | 1 | 2012 | 253 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2016 | 990 | 0.020 |
Why?
|
| Lipopolysaccharides | 1 | 2011 | 235 | 0.020 |
Why?
|
| Monocytes | 1 | 2012 | 275 | 0.020 |
Why?
|
| Insulin | 1 | 2011 | 255 | 0.020 |
Why?
|
| Time Factors | 1 | 2011 | 1848 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2012 | 1554 | 0.020 |
Why?
|
| Mice | 1 | 2011 | 6490 | 0.010 |
Why?
|